What is Elo?
Founded in 2020 by seasoned health and technology executives, Elo is at the forefront of personalized nutrition. The company leverages data to create health solutions that capitalize on the growing consumer demand for science-backed, nutrition-focused wellness. By analyzing individual biological data, Elo aims to provide tailored dietary recommendations, positioning itself as a leader in the burgeoning health-tech sector.
How much funding has Elo raised?
Elo has raised a total of $15M across 2 funding rounds:
Angel/Seed
$5M
Series A
$10M
Angel/Seed (2022): $5M with participation from Stormbreaker, Gullspång Re:food, Proxy, and Will Ventures
Series A (2023): $10M led by Octopus Ventures, Gullspång Re:food, and Will Ventures
Key Investors in Elo
Stormbreaker
Stormbreaker Ventures is an early-stage venture capital firm specializing in technologies within the connected ecosystem, including IoT, AI, and cybersecurity, aiming to support innovation in these rapidly evolving sectors.
Gullspång Re:food
Gullspång Re:food is a growth equity investor focused on visionary food companies addressing global challenges within the food system, driving sustainable change and growth in the agrifood sector.
Proxy
Proxy is a global branding and strategy agency that crafts commercially relevant brands for startups and established companies, leveraging deep expertise in revenue models and market positioning.
What's next for Elo?
With this major strategic investment, Elo is poised for significant scaling and further development of its data analytics platform. The substantial capital infusion, particularly the recent Series A financing, indicates strong investor confidence in Elo's innovative approach to health and wellness. This backing will likely fuel expansion into new markets, enhance research and development efforts, and solidify its position as a key player in the food-as-medicine movement.
See full Elo company page
